Issue 5, 2014

Biological evaluation and molecular modelling of didanosine derivatives

Abstract

Five carbonate derivatives of 5′-O-2′,3′-dideoxyinosine (DDI, 1) have been synthesized by combination with aliphatic alcohols, with their in vitro anti-HIV activity and cytotoxicity being evaluated afterward in human peripheral blood mononuclear cells (PBMCs). One particular compound, namely DDI-Penta, exhibited an outstanding performance because it was found to have both a higher inhibitory potency and a lower cytotoxicity than the lead compound, resulting in a 100× enhancement in its selectivity index. In order to further study this phenomenon, the ability of these derivatives to bind to the cytoplasmatic 5′-nucleotidase (ncN-II) was studied by in silico methods. Also, the higher calculated lipophilicity of the synthesized compounds was proposed to improve their permeability through the cell membrane since said lipophilicity would allow a higher concentration of the corresponding prodrug inside the infected cell. Overall, a combination of an optimal lipophilicity and the ability of DDI-Penta to bind to ncN-II is suggested due to the higher potency and lower cytotoxicity observed for this compound. Based on the reported findings, we believe that the combination of certain aliphatic alcohols and DDI through a carbonate linkage could significantly increase the performance of this class of therapeutic compounds; therefore, it merits further evaluations.

Graphical abstract: Biological evaluation and molecular modelling of didanosine derivatives

Supplementary files

Article information

Article type
Concise Article
Submitted
03 Jan 2014
Accepted
19 Feb 2014
First published
19 Feb 2014

Med. Chem. Commun., 2014,5, 622-631

Author version available

Biological evaluation and molecular modelling of didanosine derivatives

S. Ravetti, C. A. De Candia, M. S. Gualdesi, S. Pampuro, G. Turk, M. A. Quevedo and M. C. Briñón, Med. Chem. Commun., 2014, 5, 622 DOI: 10.1039/C4MD00003J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements